PPTDF (PeptiDream) Cyclically Adjusted PS Ratio: (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PPTDF PeptiDream Inc PPTDF
76 GF Score
Price $6.70
GF Value $5.61
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is PeptiDream Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation

PeptiDream  (OTCPK:PPTDF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

PeptiDream Cyclically Adjusted PS Ratio Related Terms

PeptiDream Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for PeptiDream's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream Cyclically Adjusted PS Ratio Chart

PeptiDream Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 31.90 17.12 20.99 11.84

PeptiDream Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.50 11.65 11.84 8.44 0.00

PPTDF vs VRTX, REGN, RVMD: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, PeptiDream's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PeptiDream Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PeptiDream's Cyclically Adjusted PS Ratio falls into.


PPTDF
76GF Score
PeptiDream Inc PPTDF
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PeptiDream Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

PeptiDream's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, PeptiDream's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/113.6000*113.6000
=0.000

Current CPI (Jun. 2026) = 113.6000.

PeptiDream Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.060 98.000 0.070
201612 0.024 98.400 0.028
201703 0.017 98.100 0.020
201706 0.240 98.500 0.277
201709 0.013 98.800 0.015
201712 0.055 99.400 0.063
201803 0.017 99.200 0.019
201806 0.392 99.200 0.449
201809 0.037 99.900 0.042
201812 0.101 99.700 0.115
201903 0.062 99.700 0.071
201906 0.317 99.800 0.361
201909 0.029 100.100 0.033
201912 0.047 100.500 0.053
202003 0.029 100.300 0.033
202006 0.201 99.900 0.229
202009 0.053 99.900 0.060
202012 0.582 99.300 0.666
202103 0.107 99.900 0.122
202106 0.322 99.500 0.368
202109 0.343 100.100 0.389
202112 0.108 100.100 0.123
202203 0.027 101.100 0.030
202206 0.265 101.800 0.296
202209 0.332 103.100 0.366
202212 0.890 104.100 0.971
202303 0.286 104.400 0.311
202306 0.243 105.200 0.262
202309 0.684 106.200 0.732
202312 0.330 106.800 0.351
202403 0.218 107.200 0.231
202406 1.557 108.200 1.635
202409 0.295 108.900 0.308
202412 0.254 110.700 0.261
202503 0.219 111.100 0.224
202506 0.231 111.700 0.235
202509 0.226 112.000 0.229
202512 0.281 113.000 0.282
202603 0.233 112.700 0.235
202606 0.000 113.600 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is PeptiDream (PPTDF) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be overvalued. The current stock price of $6.70 is trading 19.5% above its estimated GF Value™ of $5.61. GuruFocus considers PeptiDream to be Modestly Overvalued.

Key valuation signals for PPTDF:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $5.61 vs. price of $6.70 (19.5% above fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the PPTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PeptiDream Business Description

Other Exchanges 4587:Japan
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
76GF Score

Get the complete analysis for PPTDF

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.70
Price
$5.61
GF Value